Researchers present in-depth review of 145 clinical trials for Parkinson’s

A recent report conducted by researchers at The Cure Parkinson’s Trust and research advocates, presents an in-depth review of current clinical trials that are targeting Parkinson’s.

With the global number of people living with Parkinson’s expected to double by 2040, the objective of the investigation was to increase awareness of clinical trials and create opportunities for collaboration between the research community and people with the condition.

As part of the review – published in the Journal of Parkinson’s Disease – researchers categorised 145 trials into the type of drug being tested and the stage of their clinical development, to highlight trends in how the condition is being targeted.

Parkinson’s research advocate Dr Kevin McFarthing, said: “The number of clinical trials under way is encouraging for the Parkinson’s community, especially the high proportion of repurposed initiatives that increase the chances of a new therapy becoming available quickly.”

Read more:

Can negative dreams predict long-term cognitive decline in Parkinson’s?

New machine learning model could help pinpoint stages of Parkinson’s